Dinesh
Patel Ph.D., Chief Executive
Officer. Dr. Patel is a founding partner
of vSpring Capital, an early stage venture capital firm with over $180 million
of committed capital under management. Dr. Patel has been at the forefront of
biotechnology and pharmaceuticals in the Intermountain Region for the past two
decades. Dr. Patel co-founded and served as Chairman and CEO of TheraTech, a
biotechnology company that he took public and eventually sold for $350 million.
Dr. Patel also co-founded and served as Chairman and CEO of Salus Therapeutics,
a biotech company ultimately sold to Genta (GNTA). At vSpring, Dr. Patel focuses
on investing in life science companies and serves as board member/observer of
several vSpring portfolio companies including Altea Therapeutics, Exagen, Protalex,
Q Therapeutics and Inflabloc. Prior to vSpring, Dr. Patel was an active angel
investor, funding 12 companies in the biotechnology and life sciences sectors.
Dr. Patel brings to Inflabloc a wealth of life sciences industry relationships
and general startup expertise.
Peter
Friedli, Chairman. Peter
Friedli has been a principal of the investment banking firm Freidli Corporate
Finance, Inc. since 1986. Friedli Corporate Finance, Inc. is a leading Swiss
venture capital firm. Mr. Friedli has over 17 years of entrepreneurial experience
as an independent investment manager in venture capital and has specialized
in high-tech investments predominantly domiciled in the United States in the
areas of biotechniology, communications, technology and internet. He has held
interests in more than 165 venture companies ranging from start-up to pre-IPO.
Peter Friedli possesses an active involvement n the management of a number of
those companies and also serves on the board of them. He is President and Investor
Manager of New Venturetec, a Swiss publicly traded venture investment company.
Prior thereto, he worked in the field of international management consulting
for service and industrial companies in Europe and the United States.
©
Copyright 2004. Inflabloc Pharmaceuticals, Inc.. All Rights Reserved.
